178
Participants
Start Date
October 31, 2011
Primary Completion Date
July 31, 2013
Study Completion Date
July 31, 2013
Tolvaptan MR
50/80 mg capsules
Tolvaptan IR
60/30 mg capsules
Placebo
tablet
Otsuka Investigational Site, Buffalo
Otsuka Investigational Site, Bethlehem
Otsuka Investigational Site, Philadelphia
Otsuka Investigational Site, Rockville
Otsuka Investigational Site, Baltimore
Otsuka Investigational Site, Charlottesville
Otsuka Investigational Site, Chapel Hill
Otsuka Investigational Site, Anderson
Otsuka Investigational Site, Atlanta
Otsuka Investigational Site, Augusta
Otsuka Investigational Site, Jacksonville
Otsuka Investigational Site, Melbourne
Otsuka Investigational Site, Huntsville
Otsuka Investigational Site, Mobile
Otsuka Investigational Site, Nashville
Otsuka Investigational Site, Paducah
Otsuka Investigational Site, Cleveland
Otsuka Investigational Site, Mishawaka
Otsuka Investigational Site, Detroit
Otsuka Investigational Site, Rochester
Otsuka Investigational Site, Peoria
Otsuka Investigational Site, Kansas City
Otsuka Investigational Site, Shreveport
Otsuka Investigational Site, Arlington
Otsuka Investigational Site, Mission
Otsuka Investigational Site 2, Aurora
Otsuka Investigational Site, Aurora
Otsuka Investigational Site, Denver
Otsuka Investigational Site, Tempe
Otsuka Investigational Site, Peoria
Otsuka Investigational Site, Los Angeles
Otsuka Investigational Site, San Diego
Otsuka Investigational Site, New Haven
Otsuka Investigational Site, Boston
Otsuka Investigational Site, Voorhees Township
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY